The influence of dose and dosing interval on MPTP-induced dopaminergic neurotoxicity in mice
Authors:
- Patricia K. SonsallaPSPatricia K. Sonsalla
- Richard E. HeikkilaRHRichard E. Heikkila
- 1 October 1986
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 129 (3) , 339-345
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Selectivity of the Parkinsonian Neurotoxin MPTP: Toxic Metabolite MPP + Binds to NeuromelaninScience, 1986
- Differential neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in Swiss-Webster mice from different sourcesEuropean Journal of Pharmacology, 1985
- Mesolimbic dopaminergic neurons are not spared by MPTP neurotoxicity in miceEuropean Journal of Pharmacology, 1985
- Neurochemical and Histochemical Characterization of Neurotoxic Effects of 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine on Brain Catecholamine Neurones in the MouseJournal of Neurochemistry, 1985
- Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitorsNature, 1984
- Intraneuronal generation of a pyridinium metabolite may cause drug-induced parkinsonismNature, 1984
- Dopaminergic Neurotoxicity of 1-Methyl-4-Phenyl-1,2,5,6-Tetrahydropyridine in MiceScience, 1984
- Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidaseBiochemical and Biophysical Research Communications, 1984